WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aimone, L. D.
Right arrow Articles by Gebhart, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aimone, L. D.
Right arrow Articles by Gebhart, G. F.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 6, 1803-1813, Copyright © 1986 by Society for Neuroscience


ARTICLE

Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla

LD Aimone and GF Gebhart

It has been previously established that a bulbar relay plays an important role in descending inhibition of spinal dorsal horn nociceptive neurons and nociceptive reflexes produced by stimulation in the midbrain periaqueductal gray (PAG). In the present study, selected receptor antagonists were microinjected into the medial medullary nucleus raphe magnus (NRM) to determine whether descending inhibition of the tail flick (TF) reflex in the rat produced by focal electrical stimulation in the midbrain PAG was mediated by serotonin, opioid, or glutamate receptors on bulbospinal neurons in the NRM. It was determined in initial experiments that the serotonin receptor antagonist methysergide, the opioid receptor antagonist naloxone, the local anesthetic lidocaine, and the glutamate receptor antagonists gamma-D-glutamylglycine (DGG) and DL-2-amino-5-phosphonovalerate (APV) microinjected into the medulla all significantly increased the threshold of focal electrical stimulation in the medulla required to inhibit the TF reflex. The antinociceptive efficacy of agonists at opioid, serotonin, and glutamate receptors was also tested in other experiments. The microinjection of morphine (2.5-10 micrograms) into the NRM increased significantly TF latencies in a dose-dependent manner in rats in the awake or lightly anesthetized state; morphine was more potent in awake rats. Inhibition of the TF reflex produced by the microinjection of morphine was reversed by a subsequent microinjection of naloxone into the same site in the medulla. The microinjection of serotonin (5 and 10 micrograms), however, did not affect the latency of the TF reflex in either awake or lightly anesthetized rats. Glutamate (100 microM, 0.5 microliter) microinjected into the rostral ventral medulla produced an inhibition of the TF reflex of short duration that could be blocked or attenuated significantly by the glutamate receptor antagonists DGG or APV microinjected into the same site. In subsequent experiments, a nonspecific functional block was introduced adjacent to the NRM bilaterally in the medullary reticular formations (MRFs) by the microinjection of the local anesthetic lidocaine; receptor antagonists were then microinjected into the NRM and their effect on the threshold of focal electrical stimulation in the PAG to inhibit the TF reflex determined. No increase was seen in stimulation thresholds in the PAG following the microinjection of either methysergide or naloxone into the NRM. Following the microinjection of lidocaine, DGG or APV into the NRM, the stimulation threshold in the PAG for inhibition of the TF reflex was increased significantly.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. W. Winkler, S. M. Hermes, C. I. Chavkin, C. T. Drake, S. F. Morrison, and S. A. Aicher
Kappa Opioid Receptor (KOR) and GAD67 Immunoreactivity Are Found in OFF and NEUTRAL Cells in the Rostral Ventromedial Medulla
J Neurophysiol, December 1, 2006; 96(6): 3465 - 3473.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Maione, T. Bisogno, V. de Novellis, E. Palazzo, L. Cristino, M. Valenti, S. Petrosino, V. Guglielmotti, F. Rossi, and V. D. Marzo
Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 969 - 982.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
I. D. Meng, J. P. Johansen, I. Harasawa, and H. L. Fields
Kappa Opioids Inhibit Physiologically Identified Medullary Pain Modulating Neurons and Reduce Morphine Antinociception
J Neurophysiol, March 1, 2005; 93(3): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. A. Baez, T. S. Brink, and P. Mason
Roles for Pain Modulatory Cells during Micturition and Continence
J. Neurosci., January 12, 2005; 25(2): 384 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. W. Nason Jr. and P. Mason
Modulation of Sympathetic and Somatomotor Function by the Ventromedial Medulla
J Neurophysiol, July 1, 2004; 92(1): 510 - 522.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Bie and Z. Z. Pan
Presynaptic Mechanism for Anti-Analgesic and Anti-Hyperalgesic Actions of {kappa}-Opioid Receptors
J. Neurosci., August 13, 2003; 23(19): 7262 - 7268.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
V. Tortorici and M. M. Morgan
Comparison of Morphine and Kainic Acid Microinjections Into Identical PAG Sites on the Activity of RVM Neurons
J Neurophysiol, October 1, 2002; 88(4): 1707 - 1715.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kalra, M. O. Urban, and K. A. Sluka
Blockade of Opioid Receptors in Rostral Ventral Medulla Prevents Antihyperalgesia Produced by Transcutaneous Electrical Nerve Stimulation (TENS)
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 257 - 263.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
H. Bester, C. De Felipe, and S. P. Hunt
The NK1 Receptor Is Essential for the Full Expression of Noxious Inhibitory Controls in the Mouse
J. Neurosci., February 1, 2001; 21(3): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. Budai and H. L. Fields
Endogenous Opioid Peptides Acting at µ-Opioid Receptors in the Dorsal Horn Contribute to Midbrain Modulation of Spinal Nociceptive Neurons
J Neurophysiol, February 1, 1998; 79(2): 677 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Gao, Y.-H. H. Kim, and P. Mason
SEROTONERGIC Pontomedullary Neurons Are Not Activated by Antinociceptive Stimulation in the Periaqueductal Gray
J. Neurosci., May 1, 1997; 17(9): 3285 - 3292.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-